Sodium-potassium ATPase inhibition potentiates compound 48/80-induced histamine secretion from mast cells.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 1987041)

Published in Br J Pharmacol on June 01, 1984

Authors

M Amellal, M Binck, N Frossard, B Ilien, Y Landry

Articles cited by this

A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61

The interrelations between the transport of sodium and calcium in mitochondria of various mammalian tissues. Eur J Biochem (1978) 2.58

The mechanism of acetylcholine release from parasympathetic nerves. J Physiol (1971) 2.45

The effect of alkaline earth cations on the release of histamine from rat peritoneal mast cells treated with compound 48/80 and peptide 401. Br J Pharmacol (1979) 2.35

The action of sodium pump inhibitors on neuromuscular transmission. Proc R Soc Lond B Biol Sci (1968) 2.16

The effect of ouabain on the secretion of catecholamines and on the intracellular concentration of potassium. J Physiol (1967) 1.81

Increasing intracellular sodium triggers calcium release from bound pools. Nature (1976) 1.54

Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells. Agents Actions (1981) 1.53

Effect of flavone inhibitors of transport ATPases on histamine secretion from rat mast cells. Nature (1977) 1.43

Effects of sodium pump inhibitors on spontaneous acetylcholine release at the neuromuscular junction. J Physiol (1965) 1.33

On the calcium receptor activating exocytosis: inhibitory effects of calmodulin-interacting drugs on rat mast cells. J Physiol (1982) 1.26

A possible molecular mechanism of the action of digitalis: ouabain action on calcium binding to sites associated with a purified sodium-potassium-activated adenosine triphosphatase from kidney. Circ Res (1977) 1.15

Facilitation of secretion of catecholamines from rat and guinea-pig adrenal glands in potassium-free medium or after ouabain. J Physiol (1981) 1.09

Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. Biochem Pharmacol (1980) 1.08

Is the cell membrane Na+, K+ -ATPase enzyme system the pharmacological receptor for digitalis? Circ Res (1976) 1.07

Sodium-potassium ATPase, calcium, and immunological histamine release. Biochem Pharmacol (1983) 1.07

The effect of ouabain on noradrenaline output from peripheral adrenergic neurones of isolated guinea-pig vas deferens. J Physiol (1978) 1.05

Ion movements in isolated bovine adrenal medullary cells treated with ouabain. Mol Pharmacol (1983) 1.05

Ionic and metabolic requirements for stimulation of secretion by ouabain in bovine adrenal medullary cells. Mol Pharmacol (1983) 1.00

Lanthanides are transported by ionophore A23187 and mimic calcium in the histamine secretion process. Br J Pharmacol (1983) 0.95

Ethacrynic acid inhibitable Ca2+ and Mg2+-activated membrane adenosine triphosphatase in rat mast cells. Clin Exp Immunol (1977) 0.92

Na-K activated ATPase and the release of acetylcholine and noradrenaline. J Physiol (Paris) (1982) 0.91

Blocking of histamine release from human basophils in vitro by the ATPase inhibitor, ethacrynic acid. Clin Exp Immunol (1977) 0.90

Effect of lanthanide ions on histamine secretion from rat peritoneal mast cells. Br J Pharmacol (1981) 0.90

Correlations between Na+-K+ ATPase activity and acetylcholine release in rat cortical synaptosomes. J Neurochem (1981) 0.89

The effects of acetylstrophanthidin and ouabain on the sympathetic adrenergic neuroeffector junction in canine vascular smooth muscle. Circ Res (1980) 0.89

The role of cell-fixed calcium in histamine release by compound 48/80. Br J Pharmacol (1979) 0.88

Stimulus-secretion coupling in rat mast cells: inactivation of extracellular calcium dependent secretion. J Physiol (1982) 0.85

Na+ regulates release of Ca++ sequestered in synaptosomal mitochondria. Biochem Biophys Res Commun (1977) 0.83

The role of cation-activated ATPases in transmitter release from the rat iris. Q J Exp Physiol Cogn Med Sci (1980) 0.80

The Na+,K+-ATPase: a plausible trigger for voltage-independent release of cytoplasmic neurotransmitters. J Neurochem (1981) 0.79

Release of noradrenaline from the rat tail artery induced by inhibition of the sodium pump in calcium-free solution. Can J Physiol Pharmacol (1981) 0.79

Articles by these authors

G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci (1990) 2.32

Do nasal mast cells release histamine on stimulation with substance P in allergic rhinitis? Clin Exp Allergy (1994) 1.42

Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett (1990) 1.37

Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharmacol Exp Ther (1989) 1.23

Can calmodulin inhibitors be used to probe calmodulin effects? Biochem Pharmacol (1981) 1.23

Neurogenic mechanisms in bronchial inflammatory diseases. Allergy (2004) 1.22

The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther (2007) 1.16

Airway epithelium releases a relaxant factor: demonstration with substance P. Eur J Pharmacol (1986) 1.15

Arachidonic acid metabolites and airway epithelium-dependent relaxant factor. J Pharmacol Exp Ther (1987) 1.13

The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem (2001) 1.11

Natural polyamines stimulate G-proteins. Biochem J (1992) 1.10

Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am J Respir Cell Mol Biol (1996) 1.09

Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology (1994) 1.08

Sodium-potassium ATPase, calcium, and immunological histamine release. Biochem Pharmacol (1983) 1.07

Characterization of muscarinic receptors in human, guinea pig and rat lung. J Pharmacol Exp Ther (1989) 1.05

Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol Lett (1990) 1.04

A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol (1992) 1.04

Epithelial modulation of tracheal smooth muscle response to antigenic stimulation. J Appl Physiol (1985) (1986) 1.01

Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy (2004) 1.00

Effect of Hoe 140, a new B2 noncompetitive antagonist, on guinea pig tracheal bradykinin receptors. J Pharmacol Exp Ther (1992) 1.00

Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br J Pharmacol (1981) 1.00

Comparative action of new highly potent bradykinin receptor antagonists in the guinea-pig trachea. Eur J Pharmacol (1993) 0.99

Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol (2001) 0.99

Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med (1985) 0.97

Muscarinic receptor subtypes in guinea pig airways. Am J Physiol (1991) 0.96

Transport of calcium ions by Ehrlich ascites-tumour cells. Biochem J (1976) 0.95

Lanthanides are transported by ionophore A23187 and mimic calcium in the histamine secretion process. Br J Pharmacol (1983) 0.95

Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig. Neuropeptides (1993) 0.95

Plasma membrane fluidity studies by fluorescence polarization in rat mast cells stimulated by compound 48/80. Agents Actions (1985) 0.94

Solubilization of muscarinic acetylcholine receptors from mammalian brain: an analytical approach. Anal Biochem (1981) 0.94

A fluorescent hydrophobic probe used for monitoring the kinetics of exocytosis phenomena. Biochemistry (1986) 0.93

Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J (2002) 0.93

Human bronchial smooth muscle cells in culture produce stem cell factor. Eur Respir J (1999) 0.92

Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells. Mol Pharmacol (1990) 0.92

Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis (1991) 0.92

Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet. Biochim Biophys Acta (1987) 0.91

New insights into the second generation antihistamines. Drugs (2001) 0.91

Activation of CD47 receptors causes histamine secretion from mast cells. Cell Mol Life Sci (2009) 0.90

Evidence for two high-affinity bradykinin binding sites in the guinea-pig lung. Eur J Pharmacol (1991) 0.90

Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions (1985) 0.90

Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction. Mol Pharmacol (1988) 0.89

Oligomycin resistance of mitochondrial adenosine triphosphatase in a pleiotropic chromosomal mutant of a "petite-negative" yeast, Schizosaccharomyces pombe. J Biol Chem (1973) 0.89

Activation of betagamma subunits of G(i2) and G(i3) proteins by basic secretagogues induces exocytosis through phospholipase Cbeta and arachidonate release through phospholipase Cgamma in mast cells. J Immunol (2001) 0.89

Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds. Biochem Pharmacol (1981) 0.88

Interleukin-1beta induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells. Mol Pharmacol (1998) 0.88

Calcium dependent modulation of histamine release from mast cells by sodium and potassium. Agents Actions (1985) 0.88

The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway. Biochim Biophys Acta (1993) 0.88

Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. Biochem Pharmacol (1979) 0.87

Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2. J Pharmacol Exp Ther (1992) 0.87

[The bronchorelaxant effect of helicidine, a Helix pomatia extract, interferes with prostaglandin E2]. Pathol Biol (Paris) (1999) 0.87

Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions. Eur Respir J (2002) 0.87

[Type E botulism. 2 epidemics at Fort Chimo]. Union Med Can (1973) 0.86

Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Mol Pharmacol (1998) 0.86

Transmembrane sodium and potassium gradients modulate histamine secretion induced by ionophore A23187. Br J Pharmacol (1985) 0.86

In vitro bronchial hyperresponsiveness after lung transplantation in the rat. Am J Physiol (1992) 0.86

Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy (2001) 0.85

Evidence for in vitro expression of B1 receptor in the mouse trachea and urinary bladder. Br J Pharmacol (1999) 0.85

Muscarinic acetylcholine receptor: thermodynamic analysis of the interaction of agonists and antagonists. Biochim Biophys Acta (1986) 0.85

Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J (2001) 0.85

Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential. Fundam Clin Pharmacol (2000) 0.84

Modifications of mitochondrial ATPase in chromosomal respiratory-deficient mutants of a "petite-negative" yeast: Schizosaccharomyces Pombe 972h. Biochem Biophys Res Commun (1972) 0.84

Evaluation of cytotoxicity of new semi-fluorinated amphiphiles derived from dimorpholinophosphate. Biomaterials (2003) 0.84

Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: a prospective study. Eur Respir J (1998) 0.84

Resting plasma membrane potential of rat peritoneal mast cells is set predominantly by the sodium pump. FEBS Lett (1989) 0.84

Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors. Br J Pharmacol (1999) 0.83

Drugs interacting with G protein alpha subunits: selectivity and perspectives. Fundam Clin Pharmacol (1998) 0.83

Solubilization of brain muscarinic, dopaminergic and serotonergic receptors: a critical analysis. Biochem Pharmacol (1982) 0.83

Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface. Eur J Pharmacol (1998) 0.82

Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels. Int Arch Allergy Immunol (1999) 0.81

Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi. Clin Exp Allergy (2006) 0.81

Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice. Br J Pharmacol (2009) 0.81

Labelling of the inner side of granules membrane during exocytosis. A method to differentiate secretion processes. Agents Actions (1986) 0.81

Modulation by theophylline and enprofylline of the excitatory non-cholinergic transmission in guinea-pig bronchi. Eur Respir J (1992) 0.80

Solubilization of serotonin receptors from rat frontal Cortex. Biochem Pharmacol (1980) 0.80

Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy (1995) 0.80

Nerve growth factor secretion by human lung epithelial A549 cells in pro- and anti-inflammatory conditions. Eur J Pharmacol (2001) 0.80

Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity. Eur J Clin Pharmacol (1999) 0.80

Advanced glycation end products (AGEs) activate mast cells. Br J Pharmacol (2010) 0.79

Characterization of solubilized serotonin (S2) receptors in rat brain. Mol Pharmacol (1982) 0.79

Mast cell activation involves plasma membrane potential- and thapsigargin-sensitive intracellular calcium pools. Fundam Clin Pharmacol (1995) 0.79

Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists. J Neurol Sci (1990) 0.79

Separation of three cyclic-nucleotide-phosphodiesterases from bovine aorta. Biochem Biophys Res Commun (1978) 0.79

Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors. J Neurochem (1999) 0.79

Solubilized serotonin receptors from rat and dog brain. Selective labelling with [3H]ketanserin. FEBS Lett (1982) 0.79

Adenosine reduces airway excitatory non-cholinergic (e-NC) contraction through both A1 and A2 adenosine receptor activation in the guinea pig. Fundam Clin Pharmacol (1997) 0.79

Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors. Biochem Biophys Res Commun (1988) 0.79

Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli. Eur J Pharmacol (1995) 0.79

Effect of WIN 64338, a B2 bradykinin receptor antagonist on guinea-pig tracheal smooth muscle cells in culture. Fundam Clin Pharmacol (1998) 0.79

Fluorescent muscarinic EGFP-hM1 chimeric receptors: design, ligand binding and functional properties. J Recept Signal Transduct Res (1999) 0.79